5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
A clinical deep-dive into how oral micronized progesterone (Prometrium) affects bone, brain, uterine, and metabolic development in adolescents aged 12 to 17, with dosing guidance, safety data, and recommendations.
A clinical review of off-label oral micronized progesterone (Prometrium) use in adolescents ages 12 to 17, covering evidence base, dosing protocols, safety data, and prescribing considerations for primary amenorrhea, luteal phase support, and HPA-axis-related conditions.
Complete caregiver guide for giving oral micronized progesterone (Prometrium) to children under 12, including dosing considerations, safety data, administration tips, and when to call the prescriber.
A clinical review of oral micronized progesterone (Prometrium) use in pediatric patients under age 12, covering developmental safety, neuroactive steroid mechanisms, preterm birth data, and what current evidence supports.
A clinical guide to oral micronized progesterone (Prometrium) for patients 65 and older transitioning to adult care, covering dosing, safety, fall risk, and monitoring.